Fu G - Search Results

1

4-cholesten-3-one suppresses lung adenocarcinoma metastasis by regulating translocation of HMGB1, HIF1α and Caveolin-1.

Ma J, Fu G, Wu J, Han S, Zhang L, Yang M, Yu Y, Zhang M, Lin Y, Wang Y. Ma J, et al. Among authors: fu g. Cell Death Dis. 2016 Sep 22;7(9):e2372. doi: 10.1038/cddis.2016.281. Cell Death Dis. 2016. PMID: 27899819 Free PMC article.

2

The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer.

Zhang X, Zhou L, Fu G, Sun F, Shi J, Wei J, Lu C, Zhou C, Yuan Q, Yang M. Zhang X, et al. Among authors: fu g. Carcinogenesis. 2014 Sep;35(9):2062-7. doi: 10.1093/carcin/bgu103. Epub 2014 Apr 30. Carcinogenesis. 2014. PMID: 24788237

3

The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.

Zhou L, Fu G, Wei J, Shi J, Pan W, Ren Y, Xiong X, Xia J, Shen Y, Li H, Yang M. Zhou L, et al. Among authors: fu g. Oncotarget. 2016 Feb 2;7(5):5495-506. doi: 10.18632/oncotarget.6747. Oncotarget. 2016. PMID: 26716642 Free PMC article.

4

Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations.

Pan W, Zhou L, Ge M, Zhang B, Yang X, Xiong X, Fu G, Zhang J, Nie X, Li H, Tang X, Wei J, Shao M, Zheng J, Yuan Q, Tan W, Wu C, Yang M, Lin D. Pan W, et al. Among authors: fu g. Hum Mol Genet. 2016 May 1;25(9):1875-84. doi: 10.1093/hmg/ddw056. Epub 2016 Mar 2. Hum Mol Genet. 2016. PMID: 26941397

5

The allelic regulation of tumor suppressor ADARB2 in papillary thyroid carcinoma.

Li W, Wang T, Fu G, Xu Y, Zhang N, Han L, Yang M. Li W, et al. Among authors: fu g. Endocr Relat Cancer. 2022 Dec 13;30(1):e220189. doi: 10.1530/ERC-22-0189. Print 2023 Jan 1. Endocr Relat Cancer. 2022. PMID: 36305508

6

Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.

Wang J, Shen H, Fu G, Zhao D, Wang W. Wang J, et al. Among authors: fu g. Oncotarget. 2017 Feb 7;8(6):9442-9450. doi: 10.18632/oncotarget.14217. Oncotarget. 2017. PMID: 28038462 Free PMC article.

7

Survival and safety analysis of COVID-19 vaccine in Chinese patients with non-small cell lung cancer.

Xu W, Zhao J, Luan F, Zhang Z, Liu L, Zhao H, Feng B, Fu G. Xu W, et al. Among authors: fu g. Cancer Med. 2024 Apr;13(8):e7032. doi: 10.1002/cam4.7032. Cancer Med. 2024. PMID: 38651178 Free PMC article.

8

The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis.

Zhao R, Shu Y, Xu W, Jiang F, Ran P, Pan L, Wang J, Wang W, Zhao J, Wang Y, Fu G. Zhao R, et al. Among authors: fu g. Cancer Cell Int. 2024 Nov 1;24(1):361. doi: 10.1186/s12935-024-03498-9. Cancer Cell Int. 2024. PMID: 39487476 Free PMC article. Review.

9

Opportunities and challenges of immune checkpoint inhibitors for extensive-stage small-cell lung cancer.

Zhao J, Zhuo X, Liu L, Yang Z, Fu G. Zhao J, et al. Among authors: fu g. Cancer Innov. 2022 Aug 8;1(2):183-193. doi: 10.1002/cai2.23. eCollection 2022 Aug. Cancer Innov. 2022. PMID: 38090647 Free PMC article. Review.

10

The Real-world Therapeutic Analysis of First-line Immunotherapy in Chinese Patients with Drive Gene Positive for Advanced Non-Small Cell Lung Cancer.

Liu L, Li F, Zhao J, Zhuo X, Lai J, Wang J, Jiang F, Xu W, Luan F, Lin X, Yang S, Fu G. Liu L, et al. Among authors: fu g. J Cancer. 2023 Apr 1;14(6):952-965. doi: 10.7150/jca.77199. eCollection 2023. J Cancer. 2023. PMID: 37151388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,462 results

Search Page

Filters